Skip to main content
. 2001 Feb;51(2):164–168. doi: 10.1111/j.1365-2125.2001.01337.x

Table 1.

Comparison of pharmacokinetic parameters between healthy and liver disease subjects after single oral dosing of 10 mg sabeluzole tablet.

Healthy subjects (n = 10) Liver disease subjects (n = 10) 95% CI for difference Statistical significance
tmax (h) 2.4 ± 0.9 2.3 ± 1.1 −0.78; 0.98 NS
Cmax (ng ml−1) 21.6 ± 9 25.9 ± 11.0 −4.51; 13.11 NS
AUC(0,24h) (ng ml−1 h) 158 ± 110 255 ± 56 20.5; 173.5 P < 0.05
AUC(0,∝) (ng ml−1 h) 331 ± 282 681 ± 200 135.7; 564.3 P < 0.01
λz (h−1) 0.0741 ± 0.087 0.0191 ± 0.0055 0.00087–0.109 NS
t½λz (h) 17.5 ± 10.2 39.3 ± 11.5 12.3; 31.3 P < 0.001

Data represent mean±s.d. NS: no significant.